Cargando…

Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation

Although the development of hematopoietic stem cells (HSC) has been studied in great detail, their heterogeneity and relationships to different cell lineages remain incompletely understood. Moreover, the role of Vascular Adhesion Protein-1 in bone marrow hematopoiesis has remained unknown. Here we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Iftakhar-e-Khuda, Imtiaz, Pessia, Alberto, Zheng, Shuyu, Kankainen, Matti, Kontro, Mika, Karikoski, Marika, Laurila, Juha, Gerke, Heidi, Tadayon, Sina, Hollmén, Maija, Tang, Jing, Imhof, Beat A., Salmi, Marko, Jalkanen, Sirpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629906/
https://www.ncbi.nlm.nih.gov/pubmed/34719737
http://dx.doi.org/10.1007/s00018-021-03977-6
Descripción
Sumario:Although the development of hematopoietic stem cells (HSC) has been studied in great detail, their heterogeneity and relationships to different cell lineages remain incompletely understood. Moreover, the role of Vascular Adhesion Protein-1 in bone marrow hematopoiesis has remained unknown. Here we show that VAP-1, an adhesin and a primary amine oxidase producing hydrogen peroxide, is expressed on a subset of human HSC and bone marrow vasculature forming a hematogenic niche. Bulk and single-cell RNAseq analyses reveal that VAP-1(+) HSC represent a transcriptionally unique small subset of differentiated and proliferating HSC, while VAP-1(−) HSC are the most primitive HSC. VAP-1 generated hydrogen peroxide acts via the p53 signaling pathway to regulate HSC proliferation. HSC expansion and differentiation into colony-forming units are enhanced by inhibition of VAP-1. Contribution of VAP-1 to HSC proliferation was confirmed with mice deficient of VAP-1, mice expressing mutated VAP-1 and using an enzyme inhibitor. In conclusion, VAP-1 expression allows the characterization and prospective isolation of a new subset of human HSC. Since VAP-1 serves as a check point-like inhibitor in HSC differentiation, the use of VAP-1 inhibitors enables the expansion of HSC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-021-03977-6.